“…12 This study was also hampered by the inclusion of anterior dominant cancers, which may explain the observed higher proportion of anterior tumors in that series. While mpMRI and targeted biopsies significantly improve prostate cancer detection, 21,22 their utilization is not universal-primarily due to cost and, as a consequence, the results between series are not comparable. Some studies do not mention if mpMRI testing was undertaken, 13,16,33 while in another only 24.5% of the patients underwent examination by mpMRI.…”